Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
Clinical trial NCT03381274 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03381274
- Sponsor
- MedImmune LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2021-05-24
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.